Maggie is an editor for The American Journal of Managed Care® (AJMC®) and produces written, video, and podcast content covering several disease states. She joined AJMC® in 2019, and has been with AJMC®’s parent company, MJH Life Sciences®, since 2014, when she started as a copy editor.
She has a BA in English from Penn State University. You can connect with Maggie on LinkedIn.
Patients With HFpEF Administered Sacubitril/Valsartan Gain Renal Benefits
March 4th 2021Study results from Taiwan of patients with heart failure and comorbid chronic kidney disease show a drop in the risk of renal function decline among patients with heart failure with preserved ejection fraction (HFpEF) administered sacubitril/valsartan.
Read More
Mixed Improvements Seen Among Patients With MS Practicing Mindfulness
March 2nd 2021A systematic review and meta-analysis of studies of patients with multiple sclerosis (MS) found that mindfulness- and acceptance-based interventions did not have a significant effect on mindfulness among these patients.
Read More
Caring for the Whole Patient With Diabetes Drives ChristianaCare Pilot Success
March 1st 2021Collaboration enabled ChristianaCare to significantly grow its population of patients with well-controlled disease, thanks to a diabetes control roadmap that ensured both physical and emotional health needs were met through interprofessional partnerships.
Read More
HIV Care Continuum Strained Under COVID-19 Pandemic
February 27th 2021The substitution of telemedicine for many in-person HIV services during the COVID-19 pandemic has produced mixed results, with persons living with HIV increasingly lost to follow-up despite favorable views of this method of care delivery.
Read More
Varying Physical Activity for Patients With HFpEF Fails to Increase VO2 Levels
February 27th 2021A comparison of patients with heart failure with preserved ejection fraction (HFpEF) randomized to 1 of 2 physical activities did not show a significant increase in peak oxygen consumption (VO2) vs guideline-based physical activity.
Read More
Researchers Highlight Need for Pediatric-Specific Treatment, Research for MS
February 26th 2021Compared with adult-onset multiple sclerosis (MS), pediatric-onset MS has few treatments directed at the condition, specifically those that promote remyelination, enhance neuroprotection, and remediate cognitive deficits.
Read More
Study Investigates Types of Support Among Gay Men Living With, Without HIV
February 23rd 2021Georgetown investigators attempted to answer how type of supportive relationship may affect outcomes among gay men living with and without HIV, comparing results seen with primary and secondary relationships and having no support.
Read More
Cosela Approved for Protection Against Myelosuppression From SCLC Treatment
February 17th 2021The cyclin-dependent kinase 4/6 inhibitor trilaciclib (Cosela) is the first in its class to receive FDA approval as a protective agent against bone marrow loss from treatment for small cell lung cancer (SCLC).
Read More
HIV Self-testing Skyrockets Among Transgender Individuals in New Study
February 17th 2021Compared with being offered standard testing services, offers of initial and repeat self-testing led to a 3.5-fold greater uptake of testing for HIV among transgender individuals in a new study out of England and Wales.
Read More
Researchers Call for Earlier Monitoring of Cardiac Function Among High-risk Patients
February 15th 2021An analysis of 30-year data on participants from the Augusta Heart study shows that Black individuals begin to exhibit potential signs of congestive heart failure earlier than their White counterparts.
Read More
Proximity to Treatment, Racial Disparities Are Seen in Ovarian Cancer Survival
February 15th 2021Patients with ovarian cancer who lived within 10 miles of Kansas’s only National Cancer Institute–designated cancer center, and those of a non-White race, were shown to have less of a survival advantage.
Read More
Azacitidine Is Shown to Improve Overall, Relapse-Free Survival in Older Adults With AML
February 15th 2021Older adults with acute myeloid leukemia (AML) saw increased overall and relapse-free survival, as well as preserved quality of life, following oral administration of 300-mg azacitidine.
Read More
Recognize Dermatologists for Their Role in HIV, AIDS Fight, Review Says
February 10th 2021This year marks the 40th anniversary of the initial appearance in the United States of what we now know to be HIV and AIDS, first manifesting as Pneumocystis carinii pneumonia and Kaposi’s sarcoma among gay men and intravenous drug users.
Read More
Entresto Is Top HFrEF Treatment Recommendation in Updated ACC Guidelines
January 28th 2021Treatment optimization for heart failure with reduced ejection fraction is the focus of the American College of Cardiology’s 2021 update to its 2017 Expert Consensus Decision Pathway on managing patients with the condition.
Read More